Patents by Inventor Lita Suwandi

Lita Suwandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds Useful in HIV Therapy
    Publication number: 20220117993
    Abstract: The invention relates to compounds of the Formula: salts thereof, pharmaceutical compositions thereof, combinations thereof, as well as therapeutic methods of treatment and prevention.
    Type: Application
    Filed: August 8, 2019
    Publication date: April 21, 2022
    Applicants: GlaxoSmithKline Intellectual Property (No. 2) Limited, VIIV Healthcare Company
    Inventors: John Franklin MILLER, David TEMELKOFF, Emile Johann VELTHUISEN, Martha Alicia DE LA ROSA, Lita SUWANDI, B. Narasimhulu NAIDU
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20210078988
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: March 18, 2021
    Inventors: Ghotas EVINDAR, Wieslaw Mieczyslaw KAZMIERSKI, John Franklin MILLER, Vicente SAMANO, Lita SUWANDI, David TEMELKOFF, Yoshiaki WASHIO, Bing XIA
  • Isoindoline derivatives for use in the treatment of a viral infection
    Patent number: 10112899
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: October 30, 2018
    Assignee: ViiV HEALTHCARE UK LIMITED
    Inventors: Brian Alvin Johns, Emile Johann Velthuisen, Jason Gordon Weatherhead, Lita Suwandi, David Temelkoff
  • ISOINDOLINE DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION
    Publication number: 20180244617
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Application
    Filed: July 6, 2015
    Publication date: August 30, 2018
    Inventors: Brian Alvin JOHNS, Emile Johann VELTHUISEN, Jason Gordon WEATHERHEAD, Lita SUWANDI, David TEMELKOFF
  • Compounds and methods for treating HIV
    Patent number: 9163023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: October 20, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Lita Suwandi, David Temelkoff, Emile Velthuisen, Jason Gordon Weatherhead
  • COMPOUNDS AND METHODS FOR TREATING HIV
    Publication number: 20150191469
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: July 10, 2013
    Publication date: July 9, 2015
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Lita Suwandi, David Temelkoff, Emile Velthuisen, Jason Gordon Weatherhead
  • Methods of treating disease states using antiangiogenic agents
    Patent number: 8158612
    Abstract: Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: April 17, 2012
    Assignee: EntreMed, Inc.
    Inventors: Gregory E. Agoston, Jamshed H. Shah, Lita Suwandi, Theresa M. LaVallee, Anthony M. Treston
  • Substituted Pyrazole Compounds
    Publication number: 20110318393
    Abstract: Provided are substituted pyrazole compounds which are useful as protein kinase inhibitors, compositions comprising the compounds, and methods of use thereof. The protein kinase inhibitors are particularly for inhibition of Aurora A (Aurora-2) protein kinase and are useful in the treatment of diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.
    Type: Application
    Filed: November 23, 2009
    Publication date: December 29, 2011
    Applicant: MIIKANA THERAPEUTICS, INC.
    Inventors: Gaetan Ladouceur, Gregory A. Agosto, Jamshed H. Shah, Lita Suwandi, Nnamdi Ofoegbu
  • METHODS OF TREATING DISEASE STATES USING ANTIANGIOGENIC AGENTS
    Publication number: 20090105205
    Abstract: Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 23, 2009
    Applicant: ENTREMED, INC.
    Inventors: Gregory E. Agoston, Jamshed H. Shah, Lita Suwandi, Theresa M. LaVallee, Anthony M. Treston
  • Antiangiogenic agents
    Patent number: 7498322
    Abstract: Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: March 3, 2009
    Assignee: EntreMed, Inc.
    Inventors: Gregory E. Agoston, Jamshed H. Shah, Lita Suwandi, Theresa M. LaVallee, Anthony M. Treston
  • SUBSTITUTED PYRAZOLE COMPOUNDS
    Publication number: 20090029992
    Abstract: Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.
    Type: Application
    Filed: June 11, 2008
    Publication date: January 29, 2009
    Inventors: GREGORY E. AGOSTON, Anthony M. Treston, Gaetan Ladouceur, Lita Suwandi
  • Antiangiogenic agents
    Publication number: 20070004689
    Abstract: Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, or >C(H)-dioxolane, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.
    Type: Application
    Filed: July 19, 2006
    Publication date: January 4, 2007
    Inventors: Gregory Agoston, Jamshed Shah, Lita Suwandi, Theresa LaVallee, Anthony Treston
  • Compositions and methods comprising proteinase activated receptor antagonists
    Publication number: 20060063930
    Abstract: Compositions and methods comprising proteinase activated receptor antagonists are provided. More particularly, the present invention relates to the use of proteins, peptides and molecules that bind to proteinase activated receptor 2, and inhibit the processes associated with the activation of that receptor. More specifically, the present invention provides novel compositions and methods for the treatment of disorders and diseases such as those associated with abnormal cellular proliferation, angiogenesis, inflammation and cancer.
    Type: Application
    Filed: August 19, 2005
    Publication date: March 23, 2006
    Inventors: Gregory Agoston, Todd Hembrough, Theresa LaVallee, Jamshed Shah, Lita Suwandi, Anthony Treston
  • Antiangiogenic agents
    Publication number: 20050203075
    Abstract: Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.
    Type: Application
    Filed: March 11, 2005
    Publication date: September 15, 2005
    Inventors: Gregory Agoston, Jamshed Shah, Lita Suwandi, Theresa LaVallee, Anthony Treston